{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:31:41Z","timestamp":1793291501146,"version":"4.5.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T00:00:00Z","timestamp":1490400000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00198-017-4007-2","type":"journal-article","created":{"date-parts":[[2017,3,25]],"date-time":"2017-03-25T02:43:13Z","timestamp":1490409793000},"page":"2187-2193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Tumor-induced osteomalacia: experience from a South American academic center"],"prefix":"10.1007","volume":"28","author":[{"given":"G.","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Baudrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. F.","family":"Sep\u00falveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Vucetich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.","family":"Guarda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Salech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Toro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Michea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5936-3146","authenticated-orcid":false,"given":"P.","family":"Florenzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,3,25]]},"reference":[{"key":"4007_CR1","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Cancer 18:R53\u2013R77","journal-title":"Endocr Relat Cancer"},{"key":"4007_CR2","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.294.10.1260","volume":"294","author":"SM Jan de Beur","year":"2005","unstructured":"Jan de Beur SM (2005) Tumor-induced osteomalacia. JAMA 294:1260\u20131267","journal-title":"JAMA"},{"key":"4007_CR3","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/039139880903200407","volume":"32","author":"G Tsagalis","year":"2009","unstructured":"Tsagalis G, Psimenou E, Manios E, Laggouranis A (2009) Fibroblast growth factor 23 (FGF23) and the kidney. Int J Artif Organs 32:232\u2013239","journal-title":"Int J Artif Organs"},{"key":"4007_CR4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.tem.2012.07.002","volume":"23","author":"N Bhattacharyya","year":"2012","unstructured":"Bhattacharyya N, Chong WH, Gafni RI, Collins MT (2012) Fibroblast growth factor 23: state of the field and future directions. Trends Endocrinol Metab 23:610\u2013618","journal-title":"Trends Endocrinol Metab"},{"key":"4007_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2169\/internalmedicine.47.0730","volume":"47","author":"S Fukumoto","year":"2008","unstructured":"Fukumoto S (2008) Physiological regulation and disorders of phosphate metabolism\u2014pivotal role of fibroblast growth factor 23. Intern Med 47:337\u2013343","journal-title":"Intern Med"},{"key":"4007_CR6","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T et al (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"4007_CR7","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.1642","volume":"27","author":"Y Jiang","year":"2012","unstructured":"Jiang Y, Xia WB, Xing XP et al (2012) Tumor-induced osteomalacia: an important cause of adult-onset hypophosphatemic osteomalacia in China: report of 39 cases and review of the literature. J Bone Miner Res 27:1967\u20131975","journal-title":"J Bone Miner Res"},{"key":"4007_CR8","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2010-0543","volume":"95","author":"G Haeusler","year":"2010","unstructured":"Haeusler G, Freilinger M, Dominkus M, Egerbacher M, Amann G, Kolb A, Schlegel W, Raimann A, Staudenherz A (2010) Tumor-induced hypophosphatemic rickets in an adolescent boy\u2014clinical presentation, diagnosis, and histological findings in growth plate and muscle tissue. J Clin Endocrinol Metab 95:4511\u20134517","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR9","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1210\/jc.2009-0927","volume":"94","author":"K Mussig","year":"2009","unstructured":"Mussig K, Oksuz MO, Pfannenberg C, Adam P, Zustin J, Beckert S, Petersenn S (2009) Somatostatin receptor expression in an epitheloid hemangioma causing oncogenic osteomalacia. J Clin Endocrinol Metab 94:4123\u20134124","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR10","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1210\/jc.2012-3642","volume":"98","author":"RJ Clifton-Bligh","year":"2013","unstructured":"Clifton-Bligh RJ, Hofman MS, Duncan E et al (2013) Improving diagnosis of tumor-induced osteomalacia with gallium-68 DOTATATE PET\/CT. J Clin Endocrinol Metab 98:687\u2013694","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR11","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1210\/jc.2016-2052","volume":"101","author":"D El-Maouche","year":"2016","unstructured":"El-Maouche D, Sadowski SM, Papadakis GZ, Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E, Collins MT (2016) 68Ga-DOTATATE for tumor localization in tumor-induced Osteomalacia. J Clin Endocrinol Metab 101:3575\u20133581","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR12","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1097\/RLU.0000000000000854","volume":"40","author":"J Zhang","year":"2015","unstructured":"Zhang J, Zhu Z, Zhong D et al (2015) 68Ga DOTATATE PET\/CT is an accurate imaging modality in the detection of culprit tumors causing Osteomalacia. Clin Nucl Med 40:642\u2013646","journal-title":"Clin Nucl Med"},{"key":"4007_CR13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/cen.12822","volume":"84","author":"N Bhavani","year":"2016","unstructured":"Bhavani N, Reena Asirvatham A, Kallur K, Menon AS, Pavithran PV, Nair V, Vasukutty JR, Menon U, Kumar H (2016) Utility of gallium-68 DOTANOC PET\/CT in the localization of tumour-induced osteomalacia. Clin Endocrinol 84:134\u2013140","journal-title":"Clin Endocrinol"},{"key":"4007_CR14","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1097\/RLU.0000000000000460","volume":"40","author":"K Agrawal","year":"2015","unstructured":"Agrawal K, Bhadada S, Mittal BR, Shukla J, Sood A, Bhattacharya A, Bhansali A (2015) Comparison of 18F-FDG and 68Ga DOTATATE PET\/CT in localization of tumor causing oncogenic osteomalacia. Clin Nucl Med 40:e6\u2013e10","journal-title":"Clin Nucl Med"},{"key":"4007_CR15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.12426","volume":"81","author":"S Jadhav","year":"2014","unstructured":"Jadhav S, Kasaliwal R, Lele V et al (2014) Functional imaging in primary tumour-induced osteomalacia: relative performance of FDG PET\/CT vs somatostatin receptor-based functional scans: a series of nine patients. Clin Endocrinol 81:31\u201337","journal-title":"Clin Endocrinol"},{"key":"4007_CR16","first-page":"39","volume":"73","author":"EM Serafini","year":"2013","unstructured":"Serafini EM, Pisarevsky AA, Plumet Garrido J, Zamora RJ, Petrucci EA (2013) Tumor-induced osteomalacia: rhinosinusal hemangiopericytoma. Medicina (B Aires) 73:39\u201342","journal-title":"Medicina (B Aires)"},{"key":"4007_CR17","first-page":"43","volume":"73","author":"A Sanchez","year":"2013","unstructured":"Sanchez A, Castiglioni A, Coccaro N, Silva R, Bobrovsky E, Moyses RMA, Graciolli F (2013) Ostemalacia due to a tumor secreting FGF-23. Medicina-Buenos Aire 73:43\u201346","journal-title":"Medicina-Buenos Aire"},{"key":"4007_CR18","first-page":"37","volume":"75","author":"F Jerkovich","year":"2015","unstructured":"Jerkovich F, Moncet D, Babini S, Zoppi JA, Graciolli F, Oliveri B (2015) Oncogenic osteomalacia. Report of two cases. Medicina-Buenos Aire 75:37\u201340","journal-title":"Medicina-Buenos Aire"},{"key":"4007_CR19","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1590\/S0004-27302009000300014","volume":"53","author":"DD Romualdo-Silva","year":"2009","unstructured":"Romualdo-Silva DD, Silva BC, Caetano CV, Tiburcio AM, Nunes MB, Chagas SA, Polito ET, Ferreira AR, Purisch S (2009) Tumor-induced osteomalacia: a case report. Arq Bras Endocrinol Metabol 53:378\u2013382","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"4007_CR20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1590\/S0004-27302008000900016","volume":"52","author":"GL Biagini","year":"2008","unstructured":"Biagini GL, Coutinho PR, Jonasson TH, Ueda CE, Gama RR (2008) Oncogenic osteomalacia: localization of underlying peripheral tumor with 99mTc-sestamibi scintigraphy. Arq Bras Endocrinol Metabol 52:1505\u20131509","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"4007_CR21","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4067\/S0718-48162013000100009","volume":"73","author":"TSF Andrade","year":"2013","unstructured":"Andrade TSF, Gonzalez C, Cabezon R (2013) Tumor Mesenquimatico fosfaturico de fosa nasal con compromiso intracraneano: Reporte de un caso y revision de la literatura. Rev Otorrinolaringol Cir Cabeza Cuello 73:57\u201362","journal-title":"Rev Otorrinolaringol Cir Cabeza Cuello"},{"key":"4007_CR22","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1007\/s00259-008-0755-8","volume":"35","author":"C Falck von","year":"2008","unstructured":"von Falck C, Rodt T, Rosenthal H, Langer F, Goesling T, Knapp WH, Galanski M (2008) (68)Ga-DOTANOC PET\/CT for the detection of a mesenchymal tumor causing oncogenic osteomalacia. Eur J Nucl Med Mol Imaging 35:1034","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4007_CR23","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.rlu.0000257180.03964.51","volume":"32","author":"MC Roarke","year":"2007","unstructured":"Roarke MC, Nguyen BD (2007) PET\/CT localization of phosphaturic mesenchymal neoplasm causing tumor-induced osteomalacia. Clin Nucl Med 32:300\u2013301","journal-title":"Clin Nucl Med"},{"key":"4007_CR24","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1359\/jbmr.060909","volume":"22","author":"E Hesse","year":"2007","unstructured":"Hesse E, Moessinger E, Rosenthal H, Laenger F, Brabant G, Petrich T, Gratz KF, Bastian L (2007) Oncogenic osteomalacia: exact tumor localization by co-registration of positron emission and computed tomography. J Bone Miner Res 22:158\u2013162","journal-title":"J Bone Miner Res"},{"key":"4007_CR25","first-page":"e55","volume":"50","author":"R Khadgawat","year":"2009","unstructured":"Khadgawat R, Singh Y, Kansara S, Tandon N, Bal C, Seith A, Kotwal P (2009) PET\/CT localisation of a scapular haemangiopericytoma with tumour-induced osteomalacia. Singap Med J 50:e55\u2013e57","journal-title":"Singap Med J"},{"key":"4007_CR26","doi-asserted-by":"crossref","first-page":"e110","DOI":"10.1259\/bjr\/58168443","volume":"81","author":"SC Chua","year":"2008","unstructured":"Chua SC, O\u2019Connor SR, Wong WL, Ganatra RH (2008) Case report: solitary plasmacytoma of bone with oncogenic osteomalacia: recurrence of tumour confirmed by PET\/CT. A case report with a review of the radiological literature. Br J Radiol 81:e110\u2013e114","journal-title":"Br J Radiol"},{"key":"4007_CR27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4158\/EP10151.OR","volume":"17","author":"VS Jagtap","year":"2011","unstructured":"Jagtap VS, Sarathi V, Lila AR, Malhotra G, Sankhe SS, Bandgar T, Menon P, Shah NS (2011) Tumor-induced osteomalacia: a single center experience. Endocr Pract 17:177\u2013184","journal-title":"Endocr Pract"},{"key":"4007_CR28","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.revmed.2004.11.013","volume":"26","author":"JL Dupond","year":"2005","unstructured":"Dupond JL, Magy N, Mahammedi M, Prie D, Gil H, Meaux-Ruault N, Kantelip B (2005) Oncogenic osteomalacia: the role of the phosphatonins. Diagnostic usefulness of the fibroblast growth factor 23 measurement in one patient. Rev Med Interne 26:238\u2013241","journal-title":"Rev Med Interne"},{"key":"4007_CR29","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1210\/jc.2005-2105","volume":"91","author":"EA Imel","year":"2006","unstructured":"Imel EA, Peacock M, Pitukcheewanont P et al (2006) Sensitivity of fibroblast growth factor 23 measurements in tumor-induced osteomalacia. J Clin Endocrinol Metab 91:2055\u20132061","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR30","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.bone.2008.02.014","volume":"42","author":"I Endo","year":"2008","unstructured":"Endo I, Fukumoto S, Ozono K et al (2008) Clinical usefulness of measurement of fibroblast growth factor 23 (FGF23) in hypophosphatemic patients: proposal of diagnostic criteria using FGF23 measurement. Bone 42:1235\u20131239","journal-title":"Bone"},{"key":"4007_CR31","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/ncpendmet0639","volume":"3","author":"F Halperin","year":"2007","unstructured":"Halperin F, Anderson RJ, Mulder JE (2007) Tumor-induced osteomalacia: the importance of measuring serum phosphorus levels. Nat Clin Pract Endocrinol Metab 3:721\u2013725","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"4007_CR32","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1210\/jc.2011-1319","volume":"97","author":"EA Imel","year":"2012","unstructured":"Imel EA, Econs MJ (2012) Approach to the hypophosphatemic patient. J Clin Endocrinol Metab 97:696\u2013706","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR33","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1586\/eem.09.27","volume":"4","author":"EG Farrow","year":"2009","unstructured":"Farrow EG, White KE (2009) Tumor-induced osteomalacia. Expert Rev Endocrinol Metab 4:435\u2013442","journal-title":"Expert Rev Endocrinol Metab"},{"key":"4007_CR34","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1359\/jbmr.070304","volume":"22","author":"JL Geller","year":"2007","unstructured":"Geller JL, Khosravi A, Kelly MH, Riminucci M, Adams JS, Collins MT (2007) Cinacalcet in the management of tumor-induced osteomalacia. J Bone Miner Res 22:931\u2013937","journal-title":"J Bone Miner Res"},{"key":"4007_CR35","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/jbmr.275","volume":"26","author":"Y Aono","year":"2011","unstructured":"Aono Y, Hasegawa H, Yamazaki Y, Shimada T, Fujita T, Yamashita T, Fukumoto S (2011) Anti-FGF-23 neutralizing antibodies ameliorate muscle weakness and decreased spontaneous movement of Hyp mice. J Bone Miner Res 26:803\u2013810","journal-title":"J Bone Miner Res"},{"key":"4007_CR36","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","volume":"100","author":"EA Imel","year":"2015","unstructured":"Imel EA, Zhang X, Ruppe MD et al (2015) Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23. J Clin Endocrinol Metab 100:2565\u20132573","journal-title":"J Clin Endocrinol Metab"},{"key":"4007_CR37","first-page":"1217","volume":"24","author":"Y Kinoshita","year":"2014","unstructured":"Kinoshita Y, Fukumoto S (2014) Anti-FGF23 antibody therapy for patients with tumor-induced osteomalacia. Clin Calcium 24:1217\u20131222","journal-title":"Clin Calcium"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4007-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4007-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4007-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T01:14:08Z","timestamp":1533604448000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4007-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,25]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4007-2","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,25]]}}}